التفاصيل البيبلوغرافية
| العنوان: |
Comparison of surgical outcomes using Gyrus PKS™ vs LigaSure™ in total laparoscopic hysterectomy: A randomised controlled trial. |
| المؤلفون: |
Wong, Clare, Goh, Amy, Merkur, Harry |
| المصدر: |
Australian & New Zealand Journal of Obstetrics & Gynaecology; Oct2020, Vol. 60 Issue 5, p790-796, 7p |
| مصطلحات موضوعية: |
CONFIDENCE intervals, HYSTERECTOMY, INFORMED consent (Medical law), LAPAROSCOPIC surgery, OBSTETRICAL forceps, HEALTH outcome assessment, STATISTICAL sampling, SURGICAL complications, SURGICAL instruments, MATHEMATICAL variables, RANDOMIZED controlled trials, TREATMENT effectiveness, HUMAN research subjects, BLIND experiment, DATA analysis software, DESCRIPTIVE statistics, EVALUATION |
| مصطلحات جغرافية: |
AUSTRALIA |
| مستخلص: |
Background: Advanced vessel sealing devices are widely used in laparoscopic surgery. However, there remains a lack of adequately powered trials comparing laparoscopic advanced vessel sealing devices in the clinical setting, especially in gynaecology. Aims: This single‐blinded randomised controlled trial aims to compare the surgical outcomes of total laparoscopic hysterectomy (TLH) using either the Gyrus PKS™ LYONS dissecting forceps or the LigaSure™ Maryland jaw vessel sealer/divider. Materials and Methods: Women who required TLHs for benign indications were randomised to having their surgeries performed using either Gyrus PKS™ or LigaSure™. Time to haemostasis (from initial skin incision to detachment of the uterus with secured haemostasis) was the primary outcome; a 20% difference in time was considered clinically significant. Secondary outcomes measured were intra‐operative blood loss, complications, conversions, post‐operative analgesia use, and length of stay. This study was registered with the Australia New Zealand Clinical Trials Registry ACTRN12615000639516. Results: Sixty‐four women were included in the study – 33 and 31 in the Gyrus PKS™ and LigaSure™ arms, respectively. TLHs performed by LigaSure™ had statistically significantly shorter time to haemostasis compared to Gyrus PKS™ by 10.6 min (95% CI 1.3–2.0, P = 0.03). There were no differences in any of the other secondary outcomes measured. Conclusions: This trial suggests there is no difference between using either device. TLHs performed using LigaSure™ have statistically significantly shorter time to haemostasis than those using Gyrus PKS™; however, the difference is not considered clinically significant as it was only 14.2%. No other differences in surgical outcomes were detected. [ABSTRACT FROM AUTHOR] |
|
Copyright of Australian & New Zealand Journal of Obstetrics & Gynaecology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder